From GlobeNewswire

Star Equity Holdings, Inc.

Acquisition Adds Established Enterprise Client Relationships, Experienced U.S. Sales Leadership, and Back-Office Synergies

National Healthcare Properties Reports Third Quarter 2026 Results

SHOP Same Store Cash NOI increased 13.6% year-over-year —

FACT II Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

DIRTT Reports Third Quarter 2026 Financial Results

Cytek Biosciences Reports Third Quarter 2026 Financial Results

For immediate release

Beyond Meat® Reports Third Quarter 2026 Financial Results

CARRIAGE SERVICES INC

Carriage Services Announces Third Quarter 2026 Results, Updates 2026 Guidance

Arq Reports Third Quarter 2026 Results

Achieved record quarterly revenue of $38.2 million (+9% YoY) and Net income of $2.5 million

PacBio Announces Third Quarter 2026 Financial Results

electroCore Announces Third Quarter 2026 Financial Results

Third quarter 2026 net sales of $9.7 million, an increase of 12% over $8.7 million in the third quarter of 2025

Adaptive Biotechnologies Reports Third Quarter 2026 Financial Results

Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance

Creatd (CRTD) Appoints Claudia Albelais as Chief Financial Officer and Chelsea Pullano to Board of Directors

reAlpha Tech Corp. Announces Pricing of $1.75 Million Public Offering

UroGen Reports $68.0 Million of ZUSDURI Revenue and Provides Third Quarter 2026 Financial Results and Highlights

Riot Platforms Reports Third Quarter 2026 Financial Results and Strategic Highlights

Executed a 15-year, 910 critical IT MW triple-net powered land lease with a leading Frontier AI Lab at Corsicana, representing approximately $28…

WESTLAKE CHEMICAL PARTNERS LP

(713) 585-2900

Shoals Technologies Group, Inc. Reports Financial Results for Third Quarter 2026

–Quarterly Revenue of $195.3 million –

Geron Corporation Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Achieved $60.1 million in RYTELO® (imetelstat) net product revenue in Q3 2026, an increase of 5% compared to Q2 2026

BioCryst Reports Third Quarter 2026 Financial Results

Total net revenue of $180.3 million and ORLADEYO® net revenue of $174.8 million —